Fullerenols as a New Therapeutic Approach in Nanomedicine
Figure 3
Fullerenol interactions with the band 3 protein and the location of fullerenol in the lipid bilayer. Fullerenol , by associating with band 3 protein, does not only prevent its degradation, but can also influence the binding sites of spectrin, band 4.1 and 4.2 proteins, or actin, leading to changes in the cytoskeleton affecting erythrocyte morphology (from [13] modified).
